False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

Matthew C. Foy, Chloe L. Thio, Hyon S. Hwang, Melissa Saulynas, James P. Hamilton, Derek M. Fine, Mohamed G. Atta

Research output: Contribution to journalArticle

Abstract

Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.

Original languageEnglish (US)
Pages (from-to)820-822
Number of pages3
JournalClinical and Vaccine Immunology
Volume19
Issue number5
DOIs
StatePublished - May 1 2012

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States'. Together they form a unique fingerprint.

  • Cite this